NYSE:CI - CIGNA Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$172.35 -0.74 (-0.43 %)
(As of 07/17/2018 02:02 AM ET)
Previous Close$173.09
Today's Range$172.27 - $173.30
52-Week Range$163.02 - $227.13
Volume1.45 million shs
Average Volume2.13 million shs
Market Capitalization$42.11 billion
P/E Ratio16.48
Dividend Yield0.02%
CIGNA logoCigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. It operates through Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations segments. The Global Health Care segment offers medical, dental, behavioral health, vision, and prescription drug benefit plans, as well as health advocacy programs, and other products and services to insured and self-insured customers. This segment also provides Medicare Advantage and Medicare Part D plans to seniors, and Medicaid plans. The Global Supplemental Benefits segment offers supplemental health, life, and accident insurance products. The Group Disability and Life segment provides group long-term and short-term disability, group life, accident, and specialty insurance products and related services. The Other Operations segment offers corporate-owned life insurance products that are permanent insurance contracts sold to corporations to provide coverage; and run-off settlement annuity contracts. The company distributes its products and services through insurance brokers and insurance consultants; and directly to employers, unions and other groups, or individuals, as well as through direct response television and the Internet. Cigna Corporation was founded in 1792 and is headquartered in Bloomfield, Connecticut.

Receive CI News and Ratings via Email

Sign-up to receive the latest news and ratings for CI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Hospital & medical service plans
Sub-IndustryManaged Health Care


Debt-to-Equity Ratio0.37
Current Ratio0.35
Quick Ratio0.35


Trailing P/E Ratio16.48
Forward P/E Ratio13.02
P/E Growth1.08

Sales & Book Value

Annual Sales$41.62 billion
Price / Sales1.01
Cash Flow$13.0568 per share
Price / Cash13.20
Book Value$55.71 per share
Price / Book3.09


EPS (Most Recent Fiscal Year)$10.46
Net Income$2.24 billion
Net Margins5.99%
Return on Equity20.90%
Return on Assets4.76%


Outstanding Shares243,270,000
Market Cap$42,107.26

The Truth About Cryptocurrencies

CIGNA (NYSE:CI) Frequently Asked Questions

What is CIGNA's stock symbol?

CIGNA trades on the New York Stock Exchange (NYSE) under the ticker symbol "CI."

How often does CIGNA pay dividends? What is the dividend yield for CIGNA?

CIGNA announced a quarterly dividend on Wednesday, February 28th. Stockholders of record on Monday, March 12th will be paid a dividend of $0.04 per share on Tuesday, April 10th. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.09%. The ex-dividend date of this dividend is Friday, March 9th. View CIGNA's Dividend History.

How will CIGNA's stock buyback program work?

CIGNA announced that its Board of Directors has authorized a share repurchase program on Sunday, June 4th 2017, which permits the company to repurchase $3,700,000,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to buy up to 9.8% of its shares through open market purchases. Shares repurchase programs are usually an indication that the company's management believes its shares are undervalued.

How were CIGNA's earnings last quarter?

CIGNA Co. (NYSE:CI) announced its quarterly earnings results on Thursday, May, 3rd. The health services provider reported $4.11 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $3.39 by $0.72. The health services provider had revenue of $11.38 billion for the quarter, compared to analysts' expectations of $10.97 billion. CIGNA had a net margin of 5.99% and a return on equity of 20.90%. The firm's revenue for the quarter was up 8.6% compared to the same quarter last year. During the same period in the prior year, the firm posted $2.77 earnings per share. View CIGNA's Earnings History.

When is CIGNA's next earnings date?

CIGNA is scheduled to release their next quarterly earnings announcement on Thursday, August, 2nd 2018. View Earnings Estimates for CIGNA.

What guidance has CIGNA issued on next quarter's earnings?

CIGNA issued an update on its FY18 earnings guidance on Thursday, May, 3rd. The company provided EPS guidance of $12.85-13.25 for the period, compared to the Thomson Reuters consensus estimate of $12.78. The company issued revenue guidance of +7-8% to ~$44.53-44.95 billion, compared to the consensus revenue estimate of $44.08 billion.

What price target have analysts set for CI?

12 Wall Street analysts have issued 1 year price targets for CIGNA's stock. Their predictions range from $190.00 to $255.00. On average, they anticipate CIGNA's share price to reach $218.6667 in the next year. This suggests a possible upside of 26.9% from the stock's current price. View Analyst Ratings for CIGNA.

What is the consensus analysts' recommendation for CIGNA?

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CIGNA in the last year. There are currently 2 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy."

What are Wall Street analysts saying about CIGNA stock?

Here are some recent quotes from research analysts about CIGNA stock:
  • 1. According to Zacks Investment Research, "Cigna's shares have outperformed the industry in a year. The company is on track to buy Express Scripts, which should raise its rank in the health insurance industry and equip it better to face competition. Synergies from the acquisition should buoy the company's long-term growth potential. A robust Global Supplemental business, growing Government business, increasing membership, and strong capital position are the other positives. Strong 2018 outlook reflects business strength. The Zacks Consensus Estimate for 2018 earnings has improved in the past 30 days. Increase in leverage, suspension of share buyback and huge execution risk related to the recent deal are the  concerns. Its Medicare business is expected to grow less than the industry average. Recently the company has also received negative rating action." (5/28/2018)
  • 2. Jefferies Financial Group Inc analysts commented, "CI reported Q2:17 adjusted EPS of $2.91 (GAAP $3.15), compared to OPCO’s estimate of $2.46 and Street consensus of $2.45. Adjusted results exclude $0.13 of realized investment gains and $0.18 from merger-related tax benefits, offset by $0.07 of amortization expense. The beat was driven by the Healthcare segment, with the Commercial MCR of 78.7% outperforming OPCO/Street estimates by 200/160 bps. Due to the beat, the company raised FY2017 EPS guidance to $9.75-$10.05 vs. $9.35-$9.85, with all three segment outlooks growing by $15-$40M." (8/4/2017)

Who are some of CIGNA's key competitors?

Who are CIGNA's key executives?

CIGNA's management team includes the folowing people:
  • Mr. David Michael Cordani, Pres, CEO & Director (Age 53)
  • Mr. Eric Paul Palmer, Exec. VP & CFO (Age 41)
  • Ms. Nicole Susan Jones, Exec. VP & Gen. Counsel (Age 47)
  • Mr. Jason D. Sadler, Pres of International Markets (Age 49)
  • Mr. Christopher J. Hocevar, Pres of Strategy, Segments & Solutions (Age 44)

Has CIGNA been receiving favorable news coverage?

Media stories about CI stock have trended somewhat positive recently, according to Accern Sentiment Analysis. The research group identifies positive and negative press coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. CIGNA earned a media sentiment score of 0.12 on Accern's scale. They also gave news stories about the health services provider an impact score of 46.14 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company's share price in the immediate future.

Who are CIGNA's major shareholders?

CIGNA's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Swedbank (0.94%), NN Investment Partners Holdings N.V. (0.47%), Bank of Montreal Can (0.40%), DnB Asset Management AS (0.04%), Fjarde AP Fonden Fourth Swedish National Pension Fund (0.03%) and Xact Kapitalforvaltning AB (0.02%). Company insiders that own CIGNA stock include Alan Muney, Christopher J Hocevar, David Cordani, Donna F Zarcone, Hoeltzel Mary T Agoglia, Isaiah Harris, Jr, Jane E Md Henney, Jason D Sadler, John M Murabito, Lisa R Bacus, Mary T Hoeltzel, Matthew G Manders, Michael W Triplett, Nicole S Jones, Thomas A Mccarthy and William D Zollars. View Institutional Ownership Trends for CIGNA.

Which institutional investors are selling CIGNA stock?

CI stock was sold by a variety of institutional investors in the last quarter, including Bank of Montreal Can, Clinton Group Inc., Xact Kapitalforvaltning AB, Fjarde AP Fonden Fourth Swedish National Pension Fund, Cullinan Associates Inc., Gateway Investment Advisers LLC, Cobiz Wealth LLC and First American Trust FSB. Company insiders that have sold CIGNA company stock in the last year include Alan Muney, Christopher J Hocevar, David Cordani, Donna F Zarcone, Hoeltzel Mary T Agoglia, Isaiah Harris, Jr, Jane E Md Henney, Jason D Sadler, John M Murabito, Lisa R Bacus, Mary T Hoeltzel, Matthew G Manders, Michael W Triplett, Nicole S Jones and William D Zollars. View Insider Buying and Selling for CIGNA.

Which institutional investors are buying CIGNA stock?

CI stock was acquired by a variety of institutional investors in the last quarter, including Swedbank, First National Bank of Omaha, Empowered Funds LLC, NN Investment Partners Holdings N.V., Private Capital Advisors Inc., Polianta Ltd, DnB Asset Management AS and IFM Investors Pty Ltd. View Insider Buying and Selling for CIGNA.

How do I buy shares of CIGNA?

Shares of CI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is CIGNA's stock price today?

One share of CI stock can currently be purchased for approximately $172.35.

How big of a company is CIGNA?

CIGNA has a market capitalization of $42.11 billion and generates $41.62 billion in revenue each year. The health services provider earns $2.24 billion in net income (profit) each year or $10.46 on an earnings per share basis. CIGNA employs 46,000 workers across the globe.

How can I contact CIGNA?

CIGNA's mailing address is 900 COTTAGE GROVE ROAD, BLOOMFIELD CT, 06002. The health services provider can be reached via phone at 860-226-6000 or via email at [email protected]

MarketBeat Community Rating for CIGNA (NYSE CI)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  608 (Vote Outperform)
Underperform Votes:  408 (Vote Underperform)
Total Votes:  1,016
MarketBeat's community ratings are surveys of what our community members think about CIGNA and other stocks. Vote "Outperform" if you believe CI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/17/2018 by MarketBeat.com Staff

Featured Article: Short Selling

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.